ZUP1 promotes DNA repair and immune evasion to drive olaparib resistance in triple-negative breast cancer
{{output}}
Introduction: Olaparib resistance limits its therapeutic efficacy in triple-negative breast cancer (TNBC). Exploring the mechanisms underlying olaparib resistance and developing combination strategies are of great clinical signif... ...
